The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The price of Wave Life Sciences Ltd (NASDAQ: WVE) closed at $7.86 in the last session, down -0.25% from day before closing price of $7.88. In other words, the price has decreased by -$0.25 from its previous closing price. On the day, 3.28 million shares were traded. WVE stock price reached its highest trading level at $7.97 during the session, while it also had its lowest trading level at $7.24.
Ratios:
We take a closer look at WVE’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.56 and its Current Ratio is at 2.56. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Wells Fargo on October 20, 2025, initiated with a Overweight rating and assigned the stock a target price of $18.
On August 04, 2025, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $19.
On July 28, 2025, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $24.Oppenheimer initiated its Outperform rating on July 28, 2025, with a $24 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 22 ’25 when Verdine Gregory L. sold 10,000 shares for $10.00 per share. The transaction valued at 100,000 led to the insider holds 285,217 shares of the business.
BOLNO PAUL sold 217,351 shares of WVE for $2,194,810 on Aug 22 ’25. The President and CEO now owns 121,000 shares after completing the transaction at $10.10 per share. On Aug 22 ’25, another insider, PAUL BOLNO, who serves as the Director of the company, bought 217,351 shares for $9.76 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, WVE now has a Market Capitalization of 1251524736 and an Enterprise Value of 1071948032. For the stock, the TTM Price-to-Sale (P/S) ratio is 13.31 while its Price-to-Book (P/B) ratio in mrq is 8.79. Its current Enterprise Value per Revenue stands at 11.41 whereas that against EBITDA is -7.661.
Stock Price History:
The Beta on a monthly basis for WVE is -1.68, which has changed by -0.5218978 over the last 52 weeks, in comparison to a change of 0.12121439 over the same period for the S&P500. Over the past 52 weeks, WVE has reached a high of $16.74, while it has fallen to a 52-week low of $5.28. The 50-Day Moving Average of the stock is 3.63%, while the 200-Day Moving Average is calculated to be -3.66%.
Shares Statistics:
According to the various share statistics, WVE traded on average about 2.50M shares per day over the past 3-months and 4538710 shares per day over the past 10 days. A total of 155.67M shares are outstanding, with a floating share count of 127.19M. Insiders hold about 20.08% of the company’s shares, while institutions hold 84.90% stake in the company. Shares short for WVE as of 1760486400 were 13141809 with a Short Ratio of 5.25, compared to 1757894400 on 18043501. Therefore, it implies a Short% of Shares Outstanding of 13141809 and a Short% of Float of 11.17.
Earnings Estimates
The market rating of Wave Life Sciences Ltd (WVE) is currently shaped by the ongoing analysis conducted by 13.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.24, with high estimates of -$0.06 and low estimates of -$0.44.
Analysts are recommending an EPS of between -$0.88 and -$1.42 for the fiscal current year, implying an average EPS of -$1.13. EPS for the following year is -$1.14, with 13.0 analysts recommending between -$0.65 and -$1.77.
Revenue Estimates
A total of 15 analysts have provided revenue estimates for WVE’s current fiscal year. The highest revenue estimate was $85M, while the lowest revenue estimate was $17.9M, resulting in an average revenue estimate of $47.53M. In the same quarter a year ago, actual revenue was $108.3M
